• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Colchicine therapy of the renal amyloidosis of ulcerative colitis.

作者信息

Meyers S, Janowitz H D, Gumaste V V, Abramson R G, Berman L J, Venkataseshan V S, Dickman S H

机构信息

Department of Medicine, Mount Sinai School of Medicine, City University of New York, New York.

出版信息

Gastroenterology. 1988 Jun;94(6):1503-7. doi: 10.1016/0016-5085(88)90692-0.

DOI:10.1016/0016-5085(88)90692-0
PMID:3360271
Abstract

Two patients with severe proteinuria, due to renal amyloidosis complicating chronic ulcerative colitis, improved remarkably with colchicine therapy. One patient with an initial daily urine protein excretion of 13.70 g had a reduction within 2 mo to 6.50 g and to 0.37 g after 9 yr. The other patient's daily urine protein excretion was 9.00 g. This was reduced to 5.10 g/day within 3 mo and was 0.53 g/day by 8 mo. Renal function remained stable or improved during the period of therapy. Colchicine resulted in rapid and prolonged benefit for these patients, despite their amyloid-induced nephrotic syndrome.

摘要

相似文献

1
Colchicine therapy of the renal amyloidosis of ulcerative colitis.
Gastroenterology. 1988 Jun;94(6):1503-7. doi: 10.1016/0016-5085(88)90692-0.
2
[Secondary amyloidosis in ulcerative colitis--successful treatment with colchicine].
Z Gastroenterol. 1996 Nov;34(11):753-6.
3
[Renal amyloidosis complicating the outcome of chronic inflammatory colitis].肾淀粉样变性使慢性炎症性结肠炎的病情复杂化
Presse Med. 2004 Jul 31;33(13):862-5. doi: 10.1016/s0755-4982(04)98773-8.
4
Permanent improvement of renal dysfunction and proteinuria with colchicine in a patient with tumoral amyloidosis and basal cell carcinoma.秋水仙碱使一名患有肿瘤性淀粉样变性和基底细胞癌的患者的肾功能障碍和蛋白尿得到永久性改善。
Ren Fail. 2003 Jul;25(4):677-80. doi: 10.1081/jdi-120022562.
5
[Case report: secondary amyloidosis in ulcerative colitis--successful treatment with colchicine].
Z Gastroenterol. 1997 Jan;35(1):XVIII.
6
Is colchicine therapy effective in all patients with secondary amyloidosis?秋水仙碱治疗对所有继发淀粉样变性患者都有效吗?
Ren Fail. 2013 Sep;35(8):1071-4. doi: 10.3109/0886022X.2013.811345. Epub 2013 Jul 10.
7
Report on 59 patients with renal amyloidosis.59例肾淀粉样变性患者的报告。
Int Urol Nephrol. 1999;31(5):619-31. doi: 10.1023/a:1007152320216.
8
Colchicine-sensitive nephrotic syndrome due to AA amyloidosis.秋水仙碱敏感的 AA 淀粉样变性肾病综合征。
Amyloid. 2011 Sep;18(3):169-71. doi: 10.3109/13506129.2011.594823. Epub 2011 Jul 20.
9
Complete reversal of nephrotic syndrome secondary to amyloidosis with use of infliximab in a patient with inflammatory bowel disease and ankylosing spondylitis.英夫利昔单抗治疗炎症性肠病和强直性脊柱炎伴发淀粉样变性肾病综合征的完全缓解。
Ren Fail. 2011;33(5):531-3. doi: 10.3109/0886022X.2011.577543.
10
[Nephrotic syndrome in familial Mediterranean fever--effect of colchicine therapy].[家族性地中海热中的肾病综合征——秋水仙碱治疗的效果]
Ugeskr Laeger. 1995 Jul 10;157(28):4035-7.

引用本文的文献

1
Insights into renal and urological complications of inflammatory bowel disease.炎症性肠病的肾脏和泌尿系统并发症的见解
World J Nephrol. 2024 Sep 25;13(3):96574. doi: 10.5527/wjn.v13.i3.96574.
2
Two Cases of Gastric and Esophageal Amyloidosis.两例胃和食管淀粉样变性病例。
Gastroenterol Hepatol (N Y). 2009 Aug;5(8):571-574.
3
Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.炎症性肠病的肝胆表现及并发症:综述
Gastroenterology Res. 2018 Apr;11(2):83-94. doi: 10.14740/gr990w. Epub 2018 Apr 7.
4
Amyloidosis in rheumatic diseases.风湿性疾病中的淀粉样变性
Ann Rheum Dis. 1990 May;49(5):337. doi: 10.1136/ard.49.5.337-a.
5
Amyloidosis complicating inflammatory bowel disease. A case report and review of the literature.淀粉样变性并发炎症性肠病。一例病例报告及文献复习。
Dig Dis Sci. 1990 Jul;35(7):906-8. doi: 10.1007/BF01536807.
6
Colchicine--expanding horizons.秋水仙碱——拓展视野。
Postgrad Med J. 1991 Mar;67(785):223-6. doi: 10.1136/pgmj.67.785.223.